Cairo - Mubasher: The Egyptian International Pharmaceutical Industries (EIPICO), the largest subsidiary of Arab Company for Drug Industries and Medical Appliances (ACDIMA), achieved positive business results during the first half (H1) of 2021, with total sales exceeding EGP 1.540 billion, the Chairman and Managing Director, Ahmed Kelani, said.
EIPICO recorded a 45% year-on-year (YoY) growth in the value of exports to about $22.7 million, making up 23% of the total pharmaceutical exports in Egypt, Kelani added in a statement to the Egyptian Exchange (EGX) on Sunday.
The company succeeded in exporting to Venezuela, raising the number of its export markets to 70 countries.
Additionally, EIPICO topped the list of companies selling eye pharmaceutical products in Egypt during June, acquiring 23% of the total number of eye product packages sold in the market.
In the first quarter (Q1) of 2021, EIPICO posted net profits of EGP 178.06 million, down from EGP 189.1 million in Q1-20.
